Analytical Data
-
基因名
CRELD2
-
简介
CRELD2 Protein, potentially acting as a protein disulfide isomerase, may play a role in the unfolded protein response. It is also implicated in regulating the transport of the alpha4-beta2 neuronal acetylcholine receptor, showcasing its versatility in cellular processes related to protein folding and neuronal receptor dynamics. These functions suggest CRELD2's involvement in maintaining cellular homeostasis. CRELD2 Protein, Mouse (HEK293, Fc) is the recombinant mouse-derived CRELD2 protein, expressed by HEK293 , with C-hFc labeled tag.
- Application
-
别名
Cysteine-Rich With EGF-Like Domain Protein 2; CRELD2
-
种属
Mouse
-
表达系统
HEK293
-
标签
C-hFc
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9CYA0
-
表达区间
S23-L350
-
蛋白长度
Full Length of Mature Protein
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CRELD2 (Cysteine-Rich with EGF-Like Domain 2) is a member of theCRELD family of proteins, which are known to play critical roles in developmental processes and extracellular matrix regulation. This protein has garnered attention due to its implications in various pathophysiological conditions, particularly in relation to cardiovascular development and congenital heart defects. Research indicates that CRELD2 is involved in the formation of heart structures during embryogenesis, making it a potential biomarker for heart-related abnormalities. Recent studies focusing on the recombinant expression of CRELD2 have aimed at elucidating its functional roles and mechanisms at the molecular level. Generation of recombinant CRELD2 proteins allows for the investigation of its interactions with other cellular proteins and extracellular matrix components, providing insights into its biological relevance. Moreover, understanding the structure-function relationship of CRELD2 may reveal potential therapeutic targets for treating cardiovascular diseases. As such, the study of CRELD2 recombinantly is crucial for advancing our knowledge of its role in developmental biology and its potential applications in regenerative medicine and disease modeling.
